Emerging Markets, New Products Help Takeda
This article was originally published in PharmAsia News
Executive Summary
There was a noticeable emphasis on emerging markets at Takeda's results briefing for the fiscal first half, as these provided an important source of revenue growth alongside new products and helped offset the loss of exclusivity for past big sellers.